CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.46+0.13 (+9.77%)
Close on Nov 20, 2026Market cap $22.07MP/E –Yield –
CervoMed pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
CervoMed's pe ratio was 58.5× on Jul 31, 2018.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Jul 31, 2018 | 58.5× | −7.9 |
| 2014 | Jan 31, 2014 | 66.4× | +0.0 |
| 2013 | Dec 31, 2013 | 66.4× | – |
See a number that looks wrong?